Delivery Order SPE2DB20D2014-SPE2DB24FC30J

Award Date 6/24/24
Potential Completion Date 6/25/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, issued by the Defense Logistics Agency (DLA), is for the provision of RABAVERT rabies vaccine with diluents to the U.S. government. The $53,477.69 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office division, a major supplier of pharmaceutical products and medical supplies to the federal government, including the Department of Defense (DoD) and Veterans Affairs (VA). This award is part of a larger Indefinite Delivery Contract...
This federal contract award, valued at $1,352.15, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of RABAVERT rabies vaccine with diluents. The contract is a Delivery Order with a Firm Fixed Price pricing type and an ultimate completion date of August 30, 2024. AmerisourceBergen, through its Corporate Office division, is an experienced government contractor that supplies a wide range of pharmaceutical...
This federal contract award, valued at $2,476.31, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, a critical medical product for federal healthcare programs. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award is a delivery order valued at $2,613.14 issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of RABAVERT Rabies Vaccine with diluents, with a period of performance through May 31, 2023. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, valued at $1,665.76, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, a critical medical commodity used to prevent rabies infection. The award is a Delivery Order under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at $999,999,999...
This federal contract award, valued at $54,918.34, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of RABAVERT Rabies Vaccine with diluents, a critical medical product used for rabies prevention and treatment. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of RABAVERT rabies vaccine with diluents. The $3,860.60 firm fixed-price delivery order is not associated with a set-aside program. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical worth up to $999,999,999.00 through 2025, which serves as the primary vehicle for the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The $76,825.94 firm-fixed-price delivery order is for the supply of RABAVERT rabies vaccine with diluents. The award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at up to...
This federal contract award was issued by the Medical Supply Chain division of the Department of Defense (DoD) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of RABAVERT Rabies Vaccine with Diluents. The $3,860.60 firm fixed price delivery order does not have a set-aside designation. Amerisourcebergen holds a single-award Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical worth up to $999,999,999.00 through 2025,...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the procurement of RABAVERT Rabies Vaccine with diluents. The $2,316.36 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) between DLA Troop Support Medical and Amerisourcebergen, with a potential value of up to $999,999,999 through December 2025, for the supply of a comprehensive range of...
  • SPE2DB20D2014
    Indefinite Delivery Contract
  • SPE2DB20D2014-SPE2DB24FC30J
    Delivery Order

This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major supplier of pharmaceutical and medical products to the U.S. government. The $2,387.02 firm fixed price contract is for the delivery of RABAVERT Rabies Vaccine with diluents.

The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical. This single-award IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of pharmaceutical and medical commodities to DLA facilities supporting the Department of Defense worldwide. The contract does not have a set-aside designation.

Generated 9/23/24, 9:52 AM